Send us message to learn more about InnoHK
CONTACT US
Biomedical
Hong Kong Centre for Cerebro-cardiovascular Health Engineering
Reversing Cardiovascular Disease Trends with Innovative New Technologies
COCHE aims to leverage Hong Kong, as an international city at the heart of China’s Greater Bay Area, to establish a health technology ecosystem that can tackle CVDs at scale with its deep talent pool and world-class universities. With easy access to the huge patient pool across the border, we are able to bring technological and social impact worldwide.
Professor YT Zhang
Chair Professor in Biomedical Engineering at
The City University of Hong Kong
Reversing Cardiovascular Disease Trends with Innovative New Technologies
Cardiovascular disease (CVD) is the world’s leading cause of morbidity and mortality as well as the health industry’s most costly ailment for treatment. Yet, despite recent advances in its treatment, more effective and accessible ways to tackle CVDs remain to be discovered. The Hong Kong Centre for Cerebro-Cardiovascular Health Engineering (COCHE) is taking on the challenge to develop new ways to treat CVD with innovative technologies, allowing for early prediction and intervention so people can stay a step ahead of the disease. These measures can also alleviate both the human cost and the financial and social burden on the healthcare system.
COCHE is focusing on the development of groundbreaking systems to enable early diagnosis and intervention using cerebro-cardiovascular health engineering, in particular:
- Wearable technologies, including flexible sensing and soft robotics that can be worn either externally or inside the body. Sensors are being designed to help users stay healthy and in shape, monitor CVD risk factors, detect life-threatening conditions and provide on-site, real-time CVD therapies.
- Micro-nano-biosensors, which are developed and adapted to provide ultra-sensitive detection of biomarkers that would send an alert that an individual is developing the disease.
- Multi-modal and multi-scale medical imaging technologies that can be used to develop tools for precise evaluation of the vulnerability of blood plaque.
- Artificial intelligence (AI) integrating and analysing information obtained by wearable devices, biosensors and medical imaging technologies for early identification and prediction of vulnerable CVD patients.
COCHE believes deployment of a sensing- and imaging-based healthcare AI system enabling the early prevention of the diseases will lead to affordable solutions to reverse current CVD trends.
Project team members
-
Henry ChowProfessor of The Hong Kong Polytechnic University
Hong Kong -
Henry Chow
Professor of The Hong Kong Polytechnic University
In this project
You may also like
Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences
